Michel's medium: A potential alternative to cryoprotection for tissue transport in the investigation of genetic skin disease

Clinical and Experimental Dermatology

Volumn 24, Issue 6, 1999, Pages 487-489

  Woollons, A ^a,b   Holmes, G J ^a   Gratian, M J ^a   Bhogal, B S ^a   Black, M M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CRYOPROTECTION; EPIDERMOLYSIS BULLOSA; GENETIC DISORDER; GENODERMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; TISSUE PRESERVATION;

CRYOPRESERVATION; HUMANS; SKIN; SKIN DISEASES; SPECIMEN HANDLING; TISSUE PRESERVATION;

EID: 0033428438     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00540.x     Document Type: Article

References (12)

1. Vaughan Jones SA, Bhogal BS, Black MM. The use of Michel's transport media for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol 1995; 22: 365-70.
2. Nishizawa Y, Uematsu J, Owaribe K. HD4 a 180 kDa bullous pemphigoid antigen is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (Tokyo) 1993; 113: 493-501.
3. Mellerio JE, Denyer JE, Atherton DJ et al. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa. Br J Dermatol 1998; 138: 661-6.
4. Matsunaga T, Shimizu H, Ishiko A et al Localization of laminin-5 in the epidermal basement membrane. J Histochem Cytochem 1996; 44: 1223-30.
5. Shimizu H, Suzumari K, Nishikawa T. Heterogenous reactivity with LH7.2 and the first prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa. Clin Lab Invest 1996; 192: 203-7.
6. Takana T, Takahashi K, Furukawa F, Imamura S. The epitope for anti-type VII collagen monoclonal antibody (LH7.2) locates at the central region of the N-terminal non-collagenous domain of type VII collagen. Br J Dermatol 1994; 131: 472-6.
7. Bhogal B, Black MM. Diagnosis, diagnostic and research techniques. In: Wojnarowska F, Briggaman R, eds. Management of Blistering Diseases. London: Chapman & Hall, 1990: 15-34.
8. Michel B, Milner Y, David K. Preservation of tissue-fixed immunoglobulins in skin biopsies of patients with lupus erythematosus and bullous diseases. J Invest Dermatol 1973; 59: 449.
9. Skeete MVH, Black MM. The evaluation of a special liquid fixative for direct immunofluorescence. Clin Exp Dermatol 1977; 2: 49.
10. Eady RAJ, McGrath JA, McMillan JR. Ultrastructural clues to the genetic disorders of skin: The dermal-epidermal junction. J Invest Dermatol 1994; 103: 13S-18S.
11. McGrath JA, Bhogal BS, Leigh IM et al. Epidermolysis bullosa aquisita and linear IgA disease antigens are both associated with anchoring fibrils but show differences in immunolocalisation. Br J Dermatol 1993; 129: 494
12. McGrath JA, Eady RAJ. The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa. J Dermatol Sci 1997; 14: 68-75.